Athos Therapeutics

Torrance, United States

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

$35.0M raised

Feb 2024

Series B

Artificial Intelligence (AI)Biotechnology Life Science Medical

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Athos Therapeutics

How much funding has Athos Therapeutics raised?

Athos Therapeutics has raised $35.0M in total funding. The most recent round was Series B. The last funding was announced in February 2024.

Where is Athos Therapeutics headquartered?

Athos Therapeutics is headquartered in Torrance, United States.

What does Athos Therapeutics do?

Athos develops AI-based Precision Therapeutics for patients with Inflammatory Bowel, other Autoimmune Diseases, and cancer.

What stage is Athos Therapeutics at?

Athos Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 16, 2024.

MLA

"Athos Therapeutics — Funding & Investors." VCBacked, February 16, 2024, https://www.vcbacked.co/company/athos-therapeutics. Accessed June 16, 2026.

APA

VCBacked. (2024). Athos Therapeutics — Funding & Investors. Retrieved June 16, 2026, from https://www.vcbacked.co/company/athos-therapeutics

Wikipedia (cite web)

{{cite web |title=Athos Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/athos-therapeutics |website=VCBacked |access-date=June 16, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 16, 2024.

Similar Companies in Artificial Intelligence (AI)